U.S. Banks Stock News

Gold Royalty Corp. recently presented at the 2025 Precious Metals Summit in Beaver Creek, sharing updates on its growth strategy and reaffirming 2025 production guidance. Management’s focus on higher attributable production for the second half of the year highlighted both growth potential and ongoing concentration risks tied to its major producing assets. We'll examine how management’s reaffirmed 2025 guidance and production outlook shape Gold Royalty's current investment narrative and...

DiDi Global’s Bold Moves: Growth, Losses, and a Strategic Crossroads If you are watching DiDi Global (OTCPK:DIDI.Y), recent headlines likely have you weighing your next steps. The company just reported its second quarter results, with standout year-over-year sales growth set against the backdrop of a net loss. The loss stemmed largely from a hefty legal reserve as DiDi aims to resolve a lawsuit linked to its 2021 IPO. This adds a complex layer to an already dynamic story. Even with ongoing...

BioMarin Pharmaceutical (BMRN) just put a major spotlight on its pipeline by revealing fresh results from 14 studies on its flagship therapy VOXZOGO at the ASBMR 2025 meeting. The company also delivered new efficacy and safety data for PALYNZIQ at another global conference, rounding out a week marked by clinical validation for its key rare disease drugs. For investors trying to make sense of what this flurry of data means, the updates do more than just celebrate milestones; they potentially...

On September 12, 2025, Bladex successfully completed its first international Additional Tier 1 (AT1) capital issuance, raising US$200 million through perpetual, non-cumulative instruments with a 7.50% coupon and an initial seven-year call date, following very strong demand from global institutional investors. This debut of a hybrid instrument, with the offering more than three times oversubscribed, is set to strengthen Bladex's capital structure and support ongoing loan growth in line with...

If you have been tracking Cencora (COR) recently, you probably noticed the buzz after the company reached a proposed settlement agreement to resolve its ongoing stockholder derivative lawsuit tied to oversight of its controlled substance diversion programs. This agreement, still awaiting court approval, means insurance carriers will pay a substantial sum directly to Cencora. Perhaps most importantly for investors, the deal contains no admission of liability, suggesting the company can move...

If you have been watching Digital Realty Trust (DLR), there is a fresh development that might be changing the conversation: the company just introduced its Data Center Innovation Lab, or DRIL, at its Northern Virginia campus. This lab gives partners and customers the chance to test and optimize AI and hybrid cloud workloads in a real data center environment, using infrastructure from big names like AMD and Cisco. For a business helping power the world’s AI explosion, this looks like a move...

Something big just happened with G-III Apparel Group (GIII) and it is making investors take notice. A fresh earnings report delivered numbers that came up short. Sales and profits both slipped versus last year, and management did not sugarcoat it with guidance either. The outlook for both the coming quarter and the full fiscal year points to continued softness in sales and earnings, a sign that demand or execution challenges are not just a one-off. This cautious tone has clearly shaped...

In the past week, several healthcare stocks including Penumbra declined after markets pulled back despite a softer-than-expected August U.S. Producer Price Index reading that pointed towards easing inflation. This macroeconomic development has heightened expectations for a potential Federal Reserve interest rate cut, shifting investor focus to growth-oriented healthcare names like Penumbra. We'll now examine how heightened interest rate cut expectations could influence Penumbra's investment...

The Allstate Corporation recently declared approximately US$29.3 million in aggregate cash dividends on three series of preferred stock for the July 15, 2025, through October 14, 2025, period, with payouts scheduled for October 15 and a record date of September 30. This announcement highlights Allstate's ongoing commitment to consistent, meaningful distributions to preferred shareholders, further reinforcing the insurer's reputation for dividend stability and financial strength. We'll assess...

Earlier this month, May Mobility and Lyft announced the launch of their first customer-ready robotaxi pilot in Atlanta, featuring Toyota Sienna hybrid minivans equipped with autonomous driving technology and staffed by safety drivers during the initial phase. This collaboration marks Lyft’s entry into commercial autonomous vehicle services and signals broader ambitions to expand robotaxi offerings with partners like Baidu and Mobileye across additional U.S. and European markets. We'll take a...

It is not every day that you see a lineup of major institutional investors such as Amundi, Nuveen Asset Management, Bank of New York Mellon, and BNP Paribas Asset Management all boosting their stakes in Autohome (NYSE:ATHM) at roughly the same time. Combine that with Wall Street Zen’s recent upgrade from "hold" to "buy," and you have a set of signals that would catch any investor’s eye. These moves suggest increased confidence in Autohome’s direction, sparking fresh debate over what comes...

A-Mark Precious Metals, Inc. recently reported its full-year results for the period ended June 30, 2025, showing sales of US$10.98 billion compared to US$9.70 billion in the prior year, but a substantial drop in net income to US$17.32 million from US$68.55 million. Although the company achieved higher revenue, the sharp decline in net income and earnings per share stands out as a key factor attracting investor attention. Given the pronounced decrease in net income despite revenue growth,...

Northern Trust (NTRS) has drawn investor focus as its stock movement sparks new questions about where the company stands today. With ongoing shifts in the financial sector and a steady year for earnings, many are scanning for signals that could shape NTRS’s valuation outlook. Whether you are a long-time holder or just considering an entry, Northern Trust’s latest results and subtle price changes are reasons to pause and take a closer look. Looking at the bigger picture, this past year has...

If you have been tracking Air Products and Chemicals (APD), the news that the company’s new air separation facility in Cleveland is officially up and running may have caught your attention. With the plant now supplying a key onsite customer under a long-term contract, and extending its reach into the regional merchant market, APD is clearly signaling a push for deeper roots in a strategic industrial area. This expansion, paired with fresh reinvestment in the site’s existing assets, represents...

FedEx (FDX) has captured market attention as it moves forward with a sweeping restructuring plan designed to sharpen operational efficiency and support long-term growth. The spotlight is on the company’s targeted cost reductions, with over $1 billion promised through its Network 2.0 transformation and the DRIVE initiative. Investors are also watching closely as FedEx prepares to unveil its first-quarter results, with the added wrinkle of new trade tariffs pressuring its international...

Earlier this week, Hexagon Agility announced the launch of Pioneer Clean Fleet Solutions in partnership with Clean Energy Fuels Corp. and Cummins to provide comprehensive leasing of low-carbon heavy-duty commercial vehicles, featuring Cummins' new X15N natural gas engine. This move positions natural gas trucks as direct competitors to diesel on range and performance, aiming to simplify fleet decarbonization for operators across North America. We’ll explore how the launch of Pioneer Clean...

Illumina recently announced the global launch of Illumina Protein Prep, a next-generation sequencing-based proteomics assay that enables researchers worldwide to integrate proteomics into large-scale genomics studies with a streamlined solution. This launch builds on strong early-access validation and marks a significant expansion of Illumina's multiomics platform, supporting initiatives like the UK Biobank collaboration to accelerate discovery in disease research. We'll examine how the...

Zevra Therapeutics (ZVRA) has been in the spotlight after unveiling a batch of fresh positive data for MIPLYFFA, its treatment for Niemann-Pick disease type C, during the International Congress of Inborn Errors of Metabolism. The new findings shed light on MIPLYFFA’s complex approach to targeting disease at the root level and its potential to slow disease progression for patients. This update is certainly relevant if you are weighing your next move with Zevra’s stock. This announcement not...

Expro announced in early September 2025 that it achieved a world record by deploying the heaviest offshore casing string to date using the Blackhawk Gen III Wireless Top Drive Cement Head with SKYHOOK technology on a major Gulf of America project. This milestone involved industry-first capabilities that enhance safety and efficiency in the most demanding deepwater well construction environments, highlighting Expro's position at the forefront of technical innovation in offshore energy...

Evolent Health (NYSE:EVH) has landed in the spotlight after releasing a quarterly update that was a mixed bag for investors. The company reported revenues and earnings per share that missed Wall Street’s expectations, triggering a 5.3% drop in the stock price. Yet, CEO Seth Blackley took the opportunity to highlight a brightened outlook, pointing out faster-than-usual profitability targets and an accelerating new business pipeline supported by a push into AI and automation...

If you’re staring at your Peloton Interactive shares wondering what comes next, you’re definitely not alone. From its highs to its lows and everything in between, Peloton’s stock has taken investors on quite a ride. Just look at the numbers: while the last week saw a dip of 5.5% and the past month brought a 13.1% slide, zooming out to the past year, the stock is actually up 60.3%. That kind of volatility is not just noise; it is often a response to changing perceptions about the company’s...

Adtalem Global Education (ATGE) just served up a fiscal fourth-quarter performance that caught the market’s attention. The company didn’t just meet consensus expectations; it outpaced them on both earnings and revenue, with fresh enrollment growth and operational improvements acting as key drivers. This latest update has energized investor sentiment, especially as Adtalem continues rolling out new learning technology and scales up its healthcare education model. These are clear signals that...

Trying to decide whether to hold, buy, or walk away from Coca-Cola stock? You are definitely not alone. Recently, shares have been wobbling a bit, finishing the past week down 1.4% and dipping 4.9% over the last month. Yet, look a little further back and you will see the kind of steady resilience that has kept investors interested for generations, with a 22.2% gain over three years and 53.3% over five years. The story here is not just about short-term moves; it is about how the market is...

Earlier this week, O’Reilly Automotive caught attention for its strong technical momentum, consistent trading “Buy” indicators, and robust fundamentals including steady revenue and earnings growth. An interesting point is that, even with strong performance and repeated buy signals, the stock is still considered volatile and speculative, with risk management highlighted as essential for investors. With new highs and sustained buy signals in focus, we’ll consider how this technical strength...